Researchers design 'prodrug' that targets cancer cells' big appetite for glutamine, leaving healthy cells unharmed
Researchers design ‘prodrug’ that targets cancer cells’ big appetite for glutamine, leaving healthy cells unharmed
Materials provided by Johns Hopkins Medicine. Note: Content may be edited for style and length.